Restoril (temazepam) works by amplifying the effect of GABA, your brain’s primary calming chemical. It belongs to the benzodiazepine class of medications and is prescribed for short-term treatment of insomnia. In clinical trials, it reduced the time to fall asleep by about 37 minutes and increased total sleep time by roughly 99 minutes compared to placebo.
How Restoril Affects Your Brain
Your brain produces a neurotransmitter called GABA that naturally slows nerve activity. When GABA attaches to its receptor on a brain cell, it opens a tiny channel that lets chloride ions flow in, making the cell less likely to fire. This is how your brain dials down activity when it’s time to rest.
Restoril doesn’t activate these receptors on its own. Instead, it binds to a separate spot on the same receptor, located at the junction between two of its protein subunits. Once attached, it makes the receptor more sensitive to whatever GABA is already present. The practical result: GABA’s calming signals become stronger and last longer, which quiets the neural circuits that keep you awake. This is why benzodiazepines are sometimes called “positive allosteric modulators.” They turn up the volume on a signal your brain is already sending rather than creating a new one.
How Quickly It Takes Effect
After swallowing a 30 mg capsule, temazepam reaches measurable levels in the blood within 10 to 20 minutes. Blood concentrations peak at about 1.5 hours on average, which is why the medication is taken right before bed rather than hours earlier. The drug’s elimination half-life averages 8.8 hours, though it can range from 3.5 to 18.4 hours depending on the person. That range means some people clear the drug relatively quickly while others may still feel residual effects into the morning.
What Happens During Metabolism
Your liver processes temazepam primarily through a pathway called glucuronidation, which tags the drug molecule so your kidneys can filter it out. About 80 to 90 percent of a dose leaves the body this way, excreted in urine. A small fraction gets converted into oxazepam through a secondary liver pathway, but this is a minor route. Because temazepam relies mainly on glucuronidation rather than the liver enzyme pathways that many other drugs compete for, it tends to have fewer drug interaction concerns than some other benzodiazepines. That said, combining it with anything else that depresses the central nervous system, including alcohol and opioids, is dangerous and can suppress breathing.
Typical Dosing
The standard adult dose is 15 mg taken just before bedtime. Some people respond to as little as 7.5 mg, while others need 30 mg. For short-term or transient insomnia, the lower 7.5 mg dose is often enough to improve how quickly you fall asleep. Older adults typically start at 7.5 mg because they metabolize the drug more slowly, increasing the risk of excessive sedation and falls.
Clinical Results for Sleep
The American Academy of Sleep Medicine recommends temazepam for both sleep onset insomnia (difficulty falling asleep) and sleep maintenance insomnia (waking up during the night). In pooled clinical trial data, people taking temazepam fell asleep an average of 37 minutes faster than those on placebo. Total sleep time improved by an average of 99 minutes. These are meaningful gains for someone lying awake for long stretches, though individual results vary.
Common Side Effects
The most frequently reported side effects in clinical trials were drowsiness (about 9 percent of patients), dizziness (4.5 percent), and lethargy (4.5 percent). These are essentially extensions of the drug’s intended sedating effect. Next-day grogginess is possible, particularly at higher doses or in people who metabolize the drug slowly. Because temazepam’s half-life can stretch well beyond eight hours in some individuals, morning drowsiness is worth watching for, especially if you drive or operate equipment early in the day.
Dependence and Withdrawal Risks
All benzodiazepines, including Restoril, carry an FDA boxed warning about the risks of abuse, addiction, and physical dependence. Your brain adapts to the enhanced GABA signaling over time, which means stopping the drug abruptly after regular use can trigger withdrawal symptoms such as rebound insomnia, anxiety, and irritability. The risk increases with higher doses and longer use. This is a key reason Restoril is approved only for short-term treatment, generally seven to ten days.
Combining Restoril with opioid pain medications, alcohol, or other sedating substances significantly raises the risk of severe respiratory depression. The FDA specifically warns that this combination has resulted in deaths. The danger comes from stacking multiple drugs that all suppress the brain’s drive to breathe.